| Literature DB >> 30687272 |
Anja M Richter1, Mustafa Fazli1, Nadine Schmid2, Rebecca Shilling2, Angela Suppiger2, Michael Givskov1,3, Leo Eberl2, Tim Tolker-Nielsen1.
Abstract
Burkholderia cenocepacia H111 is an opportunistic pathogen associated with chronic lung infections in cystic fibrosis patients. Biofilm formation, motility and virulence of B. cenocepacia are regulated by the second messenger cyclic di-guanosine monophosphate (c-di-GMP). In the present study, we analyzed the role of all 25 putative c-di-GMP metabolizing proteins of B. cenocepacia H111 with respect to motility, colony morphology, pellicle formation, biofilm formation, and virulence. We found that RpfR is a key regulator of c-di-GMP signaling in B. cenocepacia, affecting a broad spectrum of phenotypes under various environmental conditions. In addition, we identified Bcal2449 as a regulator of B. cenocepacia virulence in Galleria mellonella larvae. While Bcal2449 consists of protein domains that may catalyze both c-di-GMP synthesis and degradation, only the latter was essential for larvae killing, suggesting that a decreased c-di-GMP level mediated by the Bcal2449 protein is required for virulence of B. cenocepacia. Finally, our work suggests that some individual proteins play a role in regulating exclusively motility (CdpA), biofilm formation (Bcam1160) or both (Bcam2836).Entities:
Keywords: Bcal2449; Burkholderia cenocepacia; Cyclic-di-GMP; GGDEF EAL domain proteins; RpfR; biofilm formation; motility
Year: 2019 PMID: 30687272 PMCID: PMC6335245 DOI: 10.3389/fmicb.2018.03286
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Bacterial strains used in this study.
| Bacterial strain | Characteristics | Reference |
|---|---|---|
| Clinical isolate from a cystic fibrosis patient | ||
| Insertional mutant with | This study | |
| Used for standard DNA manipulations | Invitrogen | |
| Host for Gateway-compatible gene replacement vectors | Invitrogen | |
| Host of the mini-Tn7-kan- |
Plasmids used in this study.
| Plasmid | Characteristics | Reference |
|---|---|---|
| pEX18Gm | Suicide vector for | |
| Pmini-Tn7- | Delivery vector for mini-Tn7-kan-gfp, Kmr | |
| pRK600 | Helper plasmid in tri- and four-parental matings; | |
| pUX-BF13 | Helper plasmid providing the Tn7 transposition functions in trans; | |
| pDAI-SceI- | Cloning vector containing the I-SceI endonuclease and | |
| pDONRPEX18Tp-SceI-pheS | Gateway compatible gene replacement vector based on SceI and pheS; Tpr | |
| pDONRPEX18Gm-SceI-pheS | Gateway compatible gene replacement vector based on SceI and pheS; Gmr | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | This study |
| pENTRPEX18Gm-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Gm-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the | |
| pENTRPEX18Tp-SceI- | Gene replacement vector containing the |
FIGURE 1Domain structure of GGDEF/EAL/HD-GYP proteins of B. cenocepacia H111. Proteins were identified by comparative BLAST analysis of well described GGDEF-, EAL- and HDY-GYP domains from E. coli and X. campestris (see text for details). Protein sequences were analyzed with Pfam and NCBI-CDD web tools. Transmembrane domains (gray squares) were verified with the TMHMM web tool. GGDEF domains are highlighted in red, EAL domains in blue and HD-GYP domains in violet, sensor domains in yellow or green. If a protein name has been assigned, it is also shown here.
FIGURE 2Motility of B. cenocepacia H111 and PDE/DGC mutants in semi-solid medium. (A) Swimming motility. Overnight cultures of B. cenocepacia H111 and mutant derivatives were adjusted to OD600 4 and inoculated into swim plates. Plates were incubated at 37°C and the relative swimming diameter was measured after 10 h. Strains with disruption of genes encoding GGDEF-only proteins are highlighted in light gray, composite GGDEF-EAL protein mutants in gray, EAL-only and HD-GYP-domain protein mutants in dark gray, respectively. Data was normalized to wild type results and shows mean swimming diameter and standard derivations of three individual experiments. Asterisks indicate P < 0.05 with unpaired t-test. (B) Swarming motility. Overnight cultures of B. cenocepacia H111 and mutant derivatives were adjusted to OD600 4.0 and inoculated on top of a swarm plate. Plates were incubated at 37°C and pictures were captured after 24 h. Data shown here are representatives of three independent experiments.
FIGURE 3Pellicle formation of B. cenocepacia H111 and the rpfR mutant in static batch cultures. Wild type and mutants were grown at 30°C in ABnoNaCl supplemented with 10 mM glucose, 10 mM glycerol or 10 mM citrate, respectively, in glass tubes and sealed with parafilm to diminish evaporation but allow air exchange. Pictures of pellicles were captured after 72 h.
FIGURE 4Macrocolony formation of the B. cenocepacia wild type, and rpfR and bcal2449 mutants on solid agar. B. cenocepacia H111 and mutant derivatives were grown on ABnoNaCl agar supplemented with 1% glucose and incubated 5 days, after which images were acquired.
FIGURE 5Biofilm formation in microtiter plates by the B. cenocepacia rpfR mutant under various medium conditions. Cells were grown in ABnoNaCl supplemented with carbon sources as indicated (see material and methods for concentrations) under static conditions at 37°C for 24 h. Subsequently, the amount of biofilm on the wells and on the pegs, respectively, was determined via a CV staining assay. Graphs show OD590nm values of CV bound by the ΔrpfR mutant normalized to values obtained from the wild type. Error bars indicate standard deviations of 4 replicates per strain, and data shown here are representatives of three independent experiments.
FIGURE 6Biofilm formation in flow-cells by B. cenocepacia H111 and the rpfR and bcal2449 mutants. (A) Confocal laser scanning micrographs of 3-day-old biofilms formed by gfp-expressing B. cenocepacia strains. The images show top-down easy3D views (B) Comstat analysis of biomass for 1, 2 and 3 day old biofilms of wild type and mutants. Figure shows mean and standard derivations of six CLSM images per strain and time point.
FIGURE 7Virulence of B. cenocepacia H111 and PDE/DGC mutants in G. mellonella. Ten larvae were infected with 10.000–20.000 B. cenocepacia wild type or mutants, and killing was observed over 3 days. Data presented here show mean and standard deviations of larvae survival of at least 3 independent experiments per strain 72 h after infection. Knockout mutants of genes coding for GGDEF-only proteins are highlighted in light gray, those encoding composite GGDEF-EAL proteins in gray, EAL-only proteins and HD-GYP-domain proteins in dark gray, wild type and Δc3 control in black, respectively. Asterisks indicate P < 0.05 with unpaired t-test with wild type control.
FIGURE 8Effect of mutations in the EAL and GGDEF domain of Bcal2449 on virulence of B. cenocepacia in G. mellonella. Ten larvae were infected with 10.000–20.000 B. cenocepacia wild type or mutants harboring pBBR1 plasmid derivatives as indicated, and larvae killing was observed over 3 days. Data presented here show mean and standard deviations of larvae survival of at least 3 independent experiments per strain and the corresponding wild type control 72 h after infection. Asterisks indicate P < 0.05 with unpaired t-test with wild type control.